How purification experts make novel drugs safe for use with a “super-effective sponge” Before life-saving vaccines and novel treatments like gene therapies can reach patients, they must meet the highest standards of purity. This means removing impurities, such as residual proteins, DNA or media, through complex, time-consuming purification processes like filtration and chromatography. For large molecules, this is particularly challenging. That’s where Sartorius BIA Separations in Slovenia comes in. The team of experts develops innovative technologies, including what they call a “super-efficient sponge”, to simplify the purification of such large molecules. Separating right from wrong quickly and efficiently, they help customers achieve the purity needed to get new treatments to the market. Discover more on the Sartorius Blog about how they are part of the solution in making safe, effective medications a reality for patients: https://sar.to/ch9gf
From research to real-world impact: Sartorius and McMaster University partner for progress Through a long-standing partnership, Sartorius and McMaster University are shaping the future of biopharmaceutical innovation. Recently, Claire Velikonja and Cindy Shu, two promising researchers from McMaster, visited Sartorius in Bohemia, New York. Their focus? Gaining hands-on experience with bioreactor processes for monoclonal antibody production. Discover how their mentorship journey with Sartorius experts bridged the gap between academia and industry — read their story on the Sartorius blog: https://sar.to/zxfy8
Advancing circular plastic use in life sciences 🔄 The recycling of sterile single-use plastics in life science research is a challenge. Now Sartorius and Covestro successfully tested the potential of closed-loop recycling of small-scale bioreactors, proving that the recycled polycarbonate can match the quality of virgin materials. The study is a step forward on the pathway to achieving more circularity in our products. Nevertheless, we are facing further challenges: How can infrastructure and processes be optimized to create sustainable solutions that meet industry's strict quality and safety requirements? Magali Barbaroux, Corporate Research Fellow at Sartorius, delves into this complex journey on the Sartorius blog. Discover why the industry's unique needs make recycling a challenge and why there's no one-size-fits-all solution: https://sar.to/z2qmj
Openness is one of the company values at Sartorius. This also means, we value diversity and are committed to fostering an inclusive environment where every voice is heard and empowered. 🌍💬 Our Employee Resource Groups (ERGs) play a crucial role in shaping this culture. These voluntary, employee-led groups, such as the Sartorius Business Women Association 👩💼 and the LGBT+ Friends Alliance 🌈, provide supportive spaces for connection, advocacy, and positive change. Discover how our ERGs are driving inclusion and help create a sense of belonging: https://sar.to/6hfy0
Forbes' World’s Best Employers 2024: Sartorius Named for the Third Year Running 🎉 Forbes magazine, in partnership with market research company Statista, conducted its eighth annual ranking of the World’s Best Employers by surveying over 300,000 employees from multinational corporations across more than 50 countries. The participants shared if they’d recommend their workplace to family or friends and rated their company on aspects such as pay, career growth opportunities, and the availability of remote work. 💰🚀🏡 Learn more about the ranking: https://sar.to/z88hk
The life science group Sartorius closed the first nine months of the fiscal year as expected, with a positive trend in demand and a robust underlying profit margin. “Following the very volatile development caused by the pandemic, the business situation has stabilized. Most customers have largely completed the reduction of their inventories, and demand for consumables business is increasing as a result. Our profit margin is at a very robust level, and we expect further positive effects from our efficiency program by the end of the year,” said Sartorius CEO Joachim Kreuzburg. “In the long term, the fundamental growth drivers of the life science and biopharmaceutical markets remain positive.” ➡️ Sales revenue almost at prior-year level ➡️ Profit margin very robust ➡️ Cash flow increased significantly ➡️ Full-year outlook for 2024 confirmed ➡️ Sartorius well-positioned for future growth Read media release:https://sar.to/1zu7y
Green sustainability at Sartorius' headquarters 🍃 Did you know that the Earth itself can power buildings? At the Sartorius Campus in Göttingen, Germany, we're doing just that! With the largest geothermal probe field in Lower Saxony, we harness the Earth's natural temperature to heat and cool three buildings.☀️❄️ This approach is a great leap towards our goal of zero avoidable emissions in Scope 1 and 2 by 2030. Curious to learn more about how this project contributes to our sustainability goals? ➡️ Dive into our latest blog post: https://ow.ly/hJT450TlGGS
Empowerment in Focus: Sartorius Business Women Association Day 2024 🌟 Yesterday, the Sartorius Business Women Association (SBWA) brought together a powerhouse of ambitious women at the "Meet the SBWA Day" event, held both onsite at Campus Göttingen and virtually. 🤝 The event featured a standout panel discussion on empowering women in leadership, led by Alexandra Gatzemeyer, Executive Board Member and Head of Lab Products & Services, and Michaela Pischke, Head of Business Area Separation Technologies. They shared personal career stories, insightful advice on leadership, and practical tips for navigating career growth while balancing life’s demands. 👩💼✨ 🔑 Key takeaway from Alexandra: “When you're young, it can be challenging to determine the direction of your career. My advice is to experiment and explore – whether it's a different role, a new function, or even another region. Be open and communicate your career ambitions clearly.“ 🔑 Key takeaway from Michaela: “Don’t be afraid to make mistakes. It’s part of the journey and they help you learn and grow further.” Here's to creating more opportunities for women to rise, lead, and thrive! 💪 Find out more about women at Sartorius: https://ow.ly/J9aa50TjHVr
Happy Birthday, Sartorius Campus! 🥳 Yesterday, 35 years ago, Horst Sartorius broke ground on the “New Plant”, laying the foundation for what we know today as the Sartorius Campus in Göttingen. Back then, the former site in downtown Göttingen (today's "Sartorius Quartier") had reached its limits. To pave the way for future growth, Sartorius embarked on building a new production site in the industrial area. The initial phase included three buildings, with one still standing in its original form today, surrounded by a campus that has evolved substantially. 🎥 Join us on a time travel to the 1980s… and back to the future. Roll the tape! 🡪 Learn more on the Sartorius Blog: https://ow.ly/O8S850T6geC
The Rise of Biologics - Have you ever wondered how biopharmaceuticals have evolved over time? Let us take you on a small journey of a big evolution. From groundbreaking blood transfusions and the first smallpox vaccine to the revolutionary development of monoclonal antibodies, the world of biologics has strongly disrupted medical treatments. Today, cell and gene therapies based on CRISPR, mRNA, and CAR-T technologies are pushing the boundaries of what's possible, offering hope for previously untreatable conditions. Yet, there is need for innovation to leverage their potential for millions who are awaiting new therapies. Join us as we explore the emergence of the most effective treatments of their time and the urgent need for faster, more efficient drug discovery and manufacturing. Find out more at: https://sar.to/fnont
